Skip to main content
. 2015 Jul 6;10(7):e0131716. doi: 10.1371/journal.pone.0131716

Fig 2. A-366 does not impact the proliferation of MCF-7 cells despite inhibition of H3K9me2.

Fig 2

(A) MCF-7 and MDA-MB-231 breast cancer cell lines were treated with the indicated concentrations of A-366 or UNC0638 for 14 days before assessing colony formation. (B) MCF-7 and MDA-MB-231 cells were treated with the indicated concentrations of A-366 or UNC0638 for 3 days and subjected to western blot analysis of global H3K9me2 and total histone H3.